1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Intervertebral Implants Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Intervertebral Implants Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate globally
5.3. Pricing Analysis
5.4. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.5. COVID-19 Pandemic Impact on Industry
6. Global Intervertebral Implants Market Analysis and Forecast, By Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast By Type, 2017–2031
6.3.1. Cervical
6.3.2. Lumbar
6.3.3. Others
6.4. Market Attractiveness By Type
7. Global Intervertebral Implants Market Analysis and Forecast, By Material
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast By Material, 2017–2031
7.3.1. Titanium
7.3.2. Polyetheretherketone (PEEK)
7.3.3. Others
7.4. Market Attractiveness By Material
8. Global Intervertebral Implants Market Analysis and Forecast, By End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast By End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Clinics and Orthopedic Centers
8.4. Market Attractiveness By End-user
9. Global Intervertebral Implants Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Intervertebral Implants Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Type, 2017–2031
10.2.1. Cervical
10.2.2. Lumbar
10.2.3. Others
10.3. Market Value Forecast By Material, 2017–2031
10.3.1. Titanium
10.3.2. Polyetheretherketone (PEEK)
10.3.3. Others
10.4. Market Value Forecast By End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Clinics and Orthopedic Centers
10.5. Market Value Forecast By Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Material
10.6.3. By End-user
10.6.4. By Country
11. Europe Intervertebral Implants Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Type, 2017–2031
11.2.1. Cervical
11.2.2. Lumbar
11.2.3. Others
11.3. Market Value Forecast By Material, 2017–2031
11.3.1. Titanium
11.3.2. Polyetheretherketone (PEEK)
11.3.3. Others
11.4. Market Value Forecast By End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Clinics and Orthopedic Centers
11.5. Market Value Forecast By Country/Sub-Region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Material
11.6.3. By End-user
11.6.4. By Country/Sub-Region
12. Asia Pacific Intervertebral Implants Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Type, 2017–2031
12.2.1. Cervical
12.2.2. Lumbar
12.2.3. Others
12.3. Market Value Forecast By Material, 2017–2031
12.3.1. Titanium
12.3.2. Polyetheretherketone (PEEK)
12.3.3. Others
12.4. Market Value Forecast By End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Clinics and Orthopedic Centers
12.5. Market Value Forecast By Country/Sub-Region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Material
12.6.3. By End-user
12.6.4. By Country/Sub-Region
13. Latin America Intervertebral Implants Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Type, 2017–2031
13.2.1. Cervical
13.2.2. Lumbar
13.2.3. Others
13.3. Market Value Forecast By Material, 2017–2031
13.3.1. Titanium
13.3.2. Polyetheretherketone (PEEK)
13.3.3. Others
13.4. Market Value Forecast By End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Clinics and Orthopedic Centers
13.5. Market Value Forecast By Country/Sub-Region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Material
13.6.3. By End-user
13.6.4. By Country/Sub-Region
14. Middle East & Africa Intervertebral Implants Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Type, 2017–2031
14.2.1. Cervical
14.2.2. Lumbar
14.2.3. Others
14.3. Market Value Forecast By Material, 2017–2031
14.3.1. Titanium
14.3.2. Polyetheretherketone (PEEK)
14.3.3. Others
14.4. Market Value Forecast By End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Clinics and Orthopedic Centers
14.5. Market Value Forecast By Country/Sub-Region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Material
14.6.3. By End-user
14.6.4. By Country/Sub-Region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
15.2. Company Profiles
15.2.1. Alphatec Spine, Inc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Financial Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Strategic Overview
15.2.2. B. Braun Melsungen AG
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Financial Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Companion Spine LLC
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Financial Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. DePuy Synthes (Johnson & Johnson)
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. Globus Medical, Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Financial Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Strategic Overview
15.2.6. LASAK s.r.o.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Financial Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Strategic Overview
15.2.7. NuVasive, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Financial Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Strategic Overview
15.2.8. Spineology Inc.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Financial Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Strategic Overview
15.2.9. Stryker Corporation
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Financial Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Strategic Overview
15.2.10. Xtant Medical
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Financial Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer